Cargando…
Preserving Ambulation in a Gene Therapy-Treated Girl Affected by Metachromatic Leukodystrophy: A Case Report
(1) Background: Atidarsagene autotemcel is a hematopoietic stem and progenitor cell gene therapy (HSPC-GT) approved to treat early-onset metachromatic leukodystrophy (MLD). The purpose of this case report is to describe the long-term management of residual gait impairment of a child with late infant...
Autores principales: | Faccioli, Silvia, Sassi, Silvia, Pandarese, Daniela, Borghi, Corrado, Montemaggiori, Valentina, Sarzana, Marina, Scarparo, Stefano, Butera, Carla, Calbi, Valeria, Aiuti, Alessandro, Fumagalli, Francesca |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10144348/ https://www.ncbi.nlm.nih.gov/pubmed/37109023 http://dx.doi.org/10.3390/jpm13040637 |
Ejemplares similares
-
Gene therapy for lysosomal storage disorders: recent advances for metachromatic leukodystrophy and mucopolysaccaridosis I
por: Penati, Rachele, et al.
Publicado: (2017) -
Intrathecal baclofen in metachromatic leukodystrophy
por: van der Veldt, Nikki, et al.
Publicado: (2018) -
Modified Delphi procedure-based expert consensus on endpoints for an international disease registry for Metachromatic Leukodystrophy: The European Metachromatic Leukodystrophy initiative (MLDi)
por: Schoenmakers, Daphne H., et al.
Publicado: (2022) -
Developing therapeutic approaches for metachromatic leukodystrophy
por: Patil, Shilpa A, et al.
Publicado: (2013) -
Diffusion tensor imaging in metachromatic leukodystrophy
por: van Rappard, Diane F., et al.
Publicado: (2018)